(EMAILWIRE.COM, December 11, 2018 ) The global radiotherapy market is segmented on the basis of type, product type, application, end user and region. Based on type, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy/brachytherapy, and systemic radiotherapy.

In 2016, the External beam radiation therapy segment accounted for a share of 91.2% of the radiotherapy market. The growth in this segment is attributed to factors such as; rising adoption of linear accelerators for the treatment of cancer and development of advanced radiotherapy technologies; development of compact advanced radiotherapy systems such as CyberKnife, Gamma Knife; increasing R&D programs; the expanding applications of these devices; and Technological developments in terms of enhanced patient comfort, superior beam focusing, easy-of-use, and affordability to patients.

Download FREE Brochure: https://tinyurl.com/yddcb4qc

On the basis of application, the prostate cancer segment held the largest share in both the internal and external beam radiotherapy markets in 2016, owing to the non-invasive nature of radiotherapy, rising incidence of prostate cancer in the geriatric male population, and high success rates achieved with radiotherapy.

North America accounted for the largest share of the global radiotherapy market in 2016, followed by Europe. The large share of the North American region is mainly attributed to the increasing healthcare expenditure in the region, technological advancements, and high adoption of radiotherapy products owing to the increasing incidence of cancer. The Asia-Pacific is expected to register the highest growth rate during the forecast period.

Request FREE SAMPLE REPORT: https://tinyurl.com/yddcb4qc

In addition, emerging markets (such as China and India) are poised to offer new growth opportunities for key radiotherapy market players during the next decade.